Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of hTERT/Survivin Multi-peptide Vaccine With Daclizumab and Prevnar for Patients With Metastatic Breast Cancer

NCT00573495 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT00573495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00573495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of hTERT/Survivin Multi-peptide Vaccine With Daclizumab and Prevnar for Patients With Metastatic Breast Cancer
Lead sponsor
University of Pennsylvania
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2007
Completion date
February 28, 2013
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast neoplasm, cancer of the breast, carcinoma, ductal